The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Open accessAbstract
Mitochondrial metabolism provides precursors to build macromolecules in growing cancer cells. In normally functioning tumour cell mitochondria, oxidative metabolism of glucose- and glutamine-derived carbon produces citrate and acetyl-coenzyme A for lipid synthesis, which is required for tumorigenesis. Yet some tumours harbour mutations in the citric acid cycle (CAC) or electron transport chain (ETC) that disable normal oxidative mitochondrial function, and it is unknown how cells from such tumours generate precursors for macromolecular synthesis. Here we show that tumour cells with defective mitochondria use glutamine-dependent reductive carboxylation rather than oxidative metabolism as the major pathway of citrate formation. This pathway uses mitochondrial and cytosolic isoforms of NADP(+)/NADPH-dependent isocitrate dehydrogenase, and subsequent metabolism of glutamine-derived citrate provides both the acetyl-coenzyme A for lipid synthesis and the four-carbon intermediates needed to produce the remaining CAC metabolites and related macromolecular precursors. This reductive, glutamine-dependent pathway is the dominant mode of metabolism in rapidly growing malignant cells containing mutations in complex I or complex III of the ETC, in patient-derived renal carcinoma cells with mutations in fumarate hydratase, and in cells with normal mitochondria subjected to acute pharmacological ETC inhibition. Our findings reveal the novel induction of a versatile glutamine-dependent pathway that reverses many of the reactions of the canonical CAC, supports tumour cell growth, and explains how cells generate pools of CAC intermediates in the face of impaired mitochondrial metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In the context of constitutive HIF-2α stabilization75 or a defective mitochondrial electron transport chain76, glutamine-derived α-KG is reductively carboxylated through the consumption of NADPH by IDH2 to generate citrate.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [76]
In the citing paper
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [630]
In the citing paper
“Previous reports showed that reductive carboxylation is a critical pathway to support the growth of tumor cells under hypoxia (Metallo, 2012; Mullen, 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Mullen, 2012
In the citing paper
“The upregulation of the reductive carboxylation pathway enhances cancer cells proliferation (Metallo, 2012; Mullen, 2012; Wise et al., 2011).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Mullen, 2012
In the citing paper
“For example, under conditions of hypoxia or impaired mitochondrial respiration, certain reactions of the TCA cycle reverse to support glutamine-dependent reductive carboxylation (92, 122, 123).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [123]
In the citing paper
“Citrate is generated by citrate synthase (CS) or through the reduction of α-ketoglutarate by isocitrate dehydrogenase (IDH).79–81”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [80]
In the citing paper
“Glutamine can contribute carbon to fatty acid synthesis via reductive carboxylation or oxidative glutaminolysis.”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Mullen et al., 2012
In the citing paper
“The former pathway is highly active in cells proliferating under hypoxia or those with a compromised respiratory chain (Metallo et al., 2012; Mullen et al., 2012; Scott et al., 2011; Wise et al., 2011), while the latter pathway has been observed in B cell lymphoma (Le et al., 2012).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Mullen et al., 2012
In the citing paper
“Although oxidation of glutamine-derived α-KG in the TCA cycle serves as a minor source of lipogenic acetyl-CoA under normal growth conditions, α-KG can be converted to citrate through reductive carboxylation under conditions of stress such as hypoxia or mitochondrial dysfunction (70–72).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [70]
In the citing paper
“In place of oxidative metabolism of both glucose and glutamine, these cancers preferentially perform reductive and carboxylating biosynthetic reactions from glutamine carbon (Le et al., 2012; Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Mullen et al., 2012
In the citing paper
“Recently three independent reports implicated IDH-dependent reductive carboxylation as playing a particularly important role in proliferating cells that exhibit decreased flux of glucose-derived pyruvate into the mitochondria. This occurs in hypoxic cells or in cells harboring defects in mitochondrial oxidative phosphorylation (Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Mullen et al., 2012
In the citing paper
“tumor cells with mutations in the TCA cycle or ETC (Mullen et al., 2011), or with hypoxia-induced suppression of oxidative metabolism (Metallo et al., 2011; Scott et al., 2011; Wise et al., 2011) use reductive carboxylation of α-KG to produce citrate and other precursors during growth.”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Mullen et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Branched tricarboxylic acid metabolism in Plasmodium falciparum
Olszewski, K. L., Mather, M. W., Morrisey, J. M., Garcia, B. A., Vaidya, A. B., Rabinowitz, J. D., & Llinás, M. (2010) · Nature · doi:10.1038/nature09301 · Cited by 124
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Self-citationGao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742
Self-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365
Self-citation
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Chen, P., Ye, C., Huang, Y., Xu, B., Wu, T., Dong, Y., Jin, Y., Zhao, L., Hu, C., Mao, J., et al. (2024) · Biological Research · doi:10.1186/s40659-024-00492-3 · Cited by 13
Self-citationMolecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors
Kitagawa, Y., Kobayashi, A., Cahill, D. P., Wakimoto, H., & Tanaka, S. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189102 · Cited by 13
Wang, J., Yu, X., Youhuan, Z., Ma, X., Gao, Y., Dejian, Z., Jie, W., Fu, Y., Shi, F., Juncheng, S., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.01.006 · Cited by 13
Low extracellular pH protects cancer cells from ammonia toxicity
Dravecka, M., Mikkola, I., Johansen, T., Seternes, O. M., & Mejlvang, J. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02440-w · Cited by 13
Metabolic rewiring caused by mitochondrial dysfunction promotes mTORC1-dependent skeletal aging
Bubb, K., Etich, J., Probst, K., Parashar, T. R., Schütter, M., Dethloff, F., Reincke, S., Nolte, J. L., Krüger, M., Schlötzer-Schrehard, U., et al. (2025) · Science Advances · doi:10.1126/sciadv.ads1842 · Cited by 14
Eroglu, B., Pang, J., Jin, X., Xi, C., Moskophidis, D., & Mivechi, N. F. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0217 · Cited by 15
Emerging Roles of Wild-type and Mutant IDH1 in Growth, Metabolism and Therapeutics of Glioma
Garrett, M. C., Fujii, Y., Osaka, N., Ito, D., Hirota, Y., & Sasaki, A. T. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.gliomas.2021.chapter4 · Cited by 14
State-of-the-art GC-MS approaches for probing central carbon metabolism
Eylem, C. C., Reçber, T., Waris, M., Kır, S., & Nemutlu, E. (2021) · Microchemical Journal · doi:10.1016/j.microc.2021.106892 · Cited by 13
Sollazzo, M., Luise, M. D., Lemma, S., Bressi, L., Iorio, M. C., Miglietta, S., Milioni, S., Kurelac, I., Iommarini, L., Gasparre, G., et al. (2021) · FEBS Journal · doi:10.1111/febs.16218 · Cited by 13
König, M., Holzhütter, H., & Berndt, N. (2013) · Biotechnology Journal · doi:10.1002/biot.201200393 · Cited by 13
Rivera‐Angulo, A., & Peña‐Ortega, F. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23330 · Cited by 13
Whole genome expression profile in neuroblastoma cells exposed to 1-methyl-4-phenylpyridine
MAZZIO, E. A., & Soliman, K. F. A. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.06.009 · Cited by 13
Gattolliat, C., Couv�, S., Meurice, G., Or�ar, C., Droin, N. M., Chiquet, M., Ferlicot, S., Verkarre, V., Vasiliu, V., Molinié, V., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4490 · Cited by 13
Sourbier, C., Ricketts, C. J., Liao, P., Matsumoto, S., Wei, D., Lang, M., Railkar, R. S., Yang, Y., Wei, M.-H., Agarwal, P. K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55003-2 · Cited by 13
Self-citationMitochondrial metabolism in TCA cycle mutant cancer cells
Sullivan, L. B., & Chandel, N. S. (2013) · Cell Cycle · doi:10.4161/cc.27513 · Cited by 15
Self-citationLiu, X., Chen, C., Zhu, S., Luo, X., Gao, L., Hu, Z., Ma, Y., Jiang, L., & Wu, Y. (2025) · Redox Report · doi:10.1080/13510002.2025.2529618 · Cited by 13
Vecchia, S. L., Doshi, S., Antonoglou, P., Kundu, T., Al-Santli, W., Avrampou, K., Witkowski, M. T., Pellattiero, A., Magrin, F., Ames, K. T., et al. (2025) · Science Advances · doi:10.1126/sciadv.adx8662 · Cited by 12
Sung, Y., Yu, Y. C., Lee, M., Lim, S., Lee, Y., Kang, M., Kwon, D., Parajulee, A., Choi, J., Min, D. S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64730-2 · Cited by 12
Mitochondria-Mediated Mechanisms of Ferroptosis in Neurological Diseases
Zhong, R., Yang, H., Li, X., Wang, F., Zhai, L., & Gao, J. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04605-6 · Cited by 12
Vacek, L., Dvořák, A., Bechyňská, K., Kosek, V., Elkalaf, M., Trinh, M. D., Fišerová, I., Pospíšilová, K., Slovakova, L., Vı́tek, L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.663625 · Cited by 12
Metabolic reprogramming in osteosarcoma
Shi, Y., Yue, X., & Luo, Q. (2023) · Pediatric Discovery · doi:10.1002/pdi3.18 · Cited by 12
Norovirus NS1/2 protein increases glutaminolysis for efficient viral replication
Hafner, A., Meurs, N., Garner, A., Azar, E., Kannan, A., Passalacqua, K. D., Nagrath, D., & Wobus, C. E. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011909 · Cited by 12
NMR-Based Stable Isotope Tracing of Cancer Metabolism
Lin, P., Lane, A. N., & Fan, T. W. ‐. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4116-3_26 · Cited by 13
Mir, R., Javid, J., Ullah, M. F., Alrdahe, S. S., Albalawi, I. A., Mustafa, S. K., Jalal, M. M., Altayar, M. A., Albalawi, A. D., Abunab, M. K., et al. (2025) · Medical Oncology · doi:10.1007/s12032-025-02945-5 · Cited by 12
ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDAC
Tran, N. L., Jiang, J., Ma, M., Gadbois, G. E., Gulay, K. C. M., Verano, A. L., Schiavon, C. R., Rebollo, E., Zhou, H., Huang, C., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01978-1 · Cited by 14
Probing Cancer Cell Metabolism Using NMR Spectroscopy
Hollinshead, K. E. R., Williams, D. S., Tennant, D. A., & Ludwig, C. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-26666-4_6 · Cited by 12
Jü, R., Fei, K., Li, S.-A., Chen, C., Zhu, L., Li, J., Zhang, D., Guo, L., & Ye, C. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.249326 · Cited by 12
Mitochondrial Tumor Suppressors—The Energetic Enemies of Tumor Progression
Jakoubě, P., Cutano, V., González-Morena, J. M., & Keckesova, Z. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0518 · Cited by 13
A mechanistic modeling framework reveals the key principles underlying tumor metabolism
Tripathi, S., Park, J. H., Pudakalakatti, S., Bhattacharya, P. K., Kaipparettu, B. A., & Levine, H. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009841 · Cited by 12
Maternal exposure to di-2-ethylhexyl phthalate (DEHP) depresses lactation capacity in mice
Hou, P., Dai, W., Jin, Y., Zhao, F., Liu, J., & Liu, H. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.155813 · Cited by 12
Yuile, A., Satgunaseelan, L., Wei, J., Kastelan, M., Back, M., Lee, M. C., Wei, H., Buckland, M. E., Lee, A. V., & Wheeler, H. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100348 · Cited by 12
Choi, S. Y. C., Ribeiro, C. F., Wang, Y. Z., Loda, M. F., Plymate, S. R., & Uo, T. (2022) · Biomolecules · doi:10.3390/biom12111590 · Cited by 13
Active Nrf2 signaling flexibly regulates HO-1 and NQO-1 in hypoxic Gansu Zokor (Eospalax cansus)
Li, M., Peng, Y., Chen, W., Gao, Y., Yang, M., Li, J., & He, J. (2022) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2022.110811 · Cited by 12
Suciu, I., Delp, J., Gutbier, S., Suess, J., Henschke, L., Celardo, I., Mayer, T. U., Amelio, I., & Leist, M. (2023) · Antioxidants · doi:10.3390/antiox13010049 · Cited by 12
Liu, R., Zhang, Z., Kyaw, A., Grabińska, K. A., Shah, H., & Shen, H. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01358-y · Cited by 11
Citrate clearance is a major function of aconitase 2 in the canonical TCA cycle
Xie, A., Brunner, J. S., Chakraborty, S., Montero, A. M., Bridgeman, A. E., Paras, K. I., Cui, R., Fagoaga-Eugui, M., Komza, M., Arnold, P. K., et al. (2026) · Cell · doi:10.1016/j.cell.2026.01.028 · Cited by 12
Rugolo, M., Zanna, C., & Ghelli, A. M. (2021) · Life · doi:10.3390/life11040351 · Cited by 13
HP1a-mediated heterochromatin formation inhibits high dietary sugar-induced tumor progression
Chang, C., Shen, Y.-C., & Yan, S. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04414-z · Cited by 12
The curious case of IDH mutant acute myeloid leukaemia: biochemistry and therapeutic approaches
Gruber, E., & Kats, L. M. (2023) · Biochemical Society Transactions · doi:10.1042/bst20230017 · Cited by 11
Metabolic Alterations in Canine Mammary Tumors
Tamarindo, G. H., Novais, A. A., Chuffa, L. G. D. A., & Zuccari, D. A. P. D. C. (2023) · Animals · doi:10.3390/ani13172757 · Cited by 14
He, Q., Yu, T., Chen, J., Liang, J., Lin, D., Yan, K., Zi-jing, X., Song, Y., & Chen, Z. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.028 · Cited by 11
Rehman, A., Marigliano, M., Torsiello, M., Noce, M. L., Papaccio, G., Tirino, V., Vecchio, V. D., & Papaccio, F. (2024) · Cancers · doi:10.3390/cancers16152769 · Cited by 11
Glutamine sensing licenses cholesterol synthesis
Garcia, B. M., Melchinger, P., Medeiros, T., Hendrix, S., Prabhu, K., Corrado, M., Kingma, J., Gorbatenko, A., Deshwal, S., Veronese, M., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00269-0 · Cited by 12
Wei, P., He, M., He, T., & Han, G. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.107919 · Cited by 11
Choudhury, F. K., Hackman, G. L., Lodi, A., & Tiziani, S. (2020) · Cancers · doi:10.3390/cancers12082147 · Cited by 12
Complex I deficiency in m.3243A>G fibroblasts is alleviated by reducing NADH accumulation
Liufu, T., Yu, H., Yu, J., Yu, M., Tian, Y., Ou, Y., Deng, J., Xing, G., & Wang, Z.-X. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1164287 · Cited by 12
IDH1 regulates phospholipid metabolism in developing astrocytes
Bogdanovic, E., Sadri, A.-R., Catapano, M. S., Vance, J. E., & Jeschke, M. G. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.09.015 · Cited by 11
Dong, W., Moon, S. J., Kelleher, J. K., & Stephanopoulos, G. N. (2019) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.9b05154 · Cited by 14
Karvelsson, S. T., Sigurdsson, A., Seip, K., Grinde, M. T., Wang, Q., Jóhannsson, F., Mælandsmo, G. M., Moestue, S. A., Rolfsson, Ó., & Halldórsson, S. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0962 · Cited by 11
HOT Models in Flux: Mitochondrial Glucose Oxidation Fuels Glioblastoma Growth
Mischel, P. S. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.05.004 · Cited by 11
The Metabolic Basis of Kidney Cancer
Srinivasan, R., George, A. K., & Linehan, W. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-17903-2_6 · Cited by 11
Self-citationSLC6A6 imports taurine into mitochondria to sustain mitochondrial translation and tumour growth
Li, L., You, J., Chai, Z.-Q., Li, X., Cai, X., Wang, L., Yang, F., Zhu, L., Mi, W., Xia, X., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01455-6 · Cited by 10
Mapping the Metabolic Niche of Citrate Metabolism and SLC13A5
Chen, F., Willenbockel, H. F., & Cordes, T. (2023) · Metabolites · doi:10.3390/metabo13030331 · Cited by 10
Intranuclear TCA and mitochondrial overload: The nascent sprout of tumors metabolism
Yuan, W., Lu, G., Zhao, Y., He, X., Liao, S., Wang, Z., Lei, X., Xie, Z., Yang, X., Tang, S., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217527 · Cited by 13
Computational modeling of cancer cell metabolism along the catabolic-anabolic axes
Castrejon, J. V., Levine, H., Kaipparettu, B. A., Onuchic, J. N., George, J. T., & Jia, D. (2025) · npj Systems Biology and Applications · doi:10.1038/s41540-025-00525-x · Cited by 10
Zhao, M., Zhang, D., Jiang, H., Kuganesan, N., Natarajan, S., Pu, L., Thakkar, K. N., Zhao, H., Le, Q., Giaccia, A. J., et al. (2025) · Science Advances · doi:10.1126/sciadv.adv2417 · Cited by 10
Luo, Q., Wang, Q., Shi, J., Lv, Q., Dong, Z., Li, W., Xia, Y., Liu, J., & Yang, H. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07782-y · Cited by 10
Jiang, H., Tiche, S. J., He, C. J., Liu, J., Bian, F., Jedoui, M., Forgo, B. L., Islam, M. T., Zhao, M., Emengo, P. O., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2502483122 · Cited by 10
Self-citationCurtabbi, A., Jaroszewicz, S. N., Sanz-Cortés, R., Acín‐Pérez, R., Prymidis, D., Cherevatenko, M., de Mena, R. M., Esteban-Amo, M. J., de la Fuente, M. Á., Frezza, C., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01454-7 · Cited by 10
Hart, M. L., Sokolov, D., Danquah, S., Zheng, E., Doan, A. D., Davidsen, K., MacPherson, D. P., & Sullivan, L. B. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01524-w · Cited by 10
Self-citationPaul, M. S., & Zachar, Z. (2012) · InTech eBooks · doi:10.5772/48582 · Cited by 10
Over-Reduced State of Mitochondria as a Trigger of “β-Oxidation Shuttle” in Cancer Cells
Zhelev, Z., Sumiyoshi, A., Aoki, I., Lazarova, D., Vlaykova, T. I., Higashi, T., & Bakalova, R. (2022) · Cancers · doi:10.3390/cancers14040871 · Cited by 10
Žuna, K., Tyschuk, T., Beikbaghban, T., Sternberg, F., Kreiter, J., & Pohl, E. E. (2024) · Acta Physiologica · doi:10.1111/apha.14143 · Cited by 10
The role of metabolic reprogramming in kidney cancer
Chen, Z., & Zhang, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1402351 · Cited by 11
How do reducing equivalents increase insulin secretion?
Attie, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci84011 · Cited by 12
Hu, Y., Gao, A., Liao, H., Zhang, M., Xu, G., Gao, L., Xu, L., Zhou, Y., Gao, J., Ye, Q., et al. (2018) · Archiv der Pharmazie · doi:10.1002/ardp.201800039 · Cited by 10
Emerging Therapies for Advanced Clear Cell Renal Cell Carcinoma
Toth, A. T., & Cho, D. C. (2020) · Journal of Kidney Cancer and VHL · doi:10.15586/jkcvhl.2020.156 · Cited by 10
Comparison of Amino Acid Metabolisms in Normal Prostate (PNT-1A) and Cancer Cells (PC-3)
Arslan, E., & Koyuncu, İ. (2021) · ONCOLOGIE · doi:10.32604/oncologie.2021.014764 · Cited by 10
Kurashige, T., Shimamura, M. I., Hamada, K., Matsuse, M., Mitsutake, N., & Nagayama, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-27461-2 · Cited by 10
Warburg effect and renal cancer caused by errs in fumarate hydratase encoding gene
Qureshi, A. S., & Ali, S. (2019) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps/32/2/01.03.2019/4965/743-749 · Cited by 11
Global Metabolite Profiling of Human Colorectal Cancer Xenografts in Mice Using HPLC–MS/MS
Loftus, N. J., Lai, L., Wilkinson, R. W., Odedra, R., Wilson, I. D., & Barnes, A. J. (2013) · Journal of Proteome Research · doi:10.1021/pr400260h · Cited by 10
Cancer Metabolism under Limiting Oxygen ConditionsPreprint
Kim, L. C., Lesner, N. P., & Simon, M. C. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041542 · Cited by 11
GLP-1 signaling in tumor metabolism and immunity: mechanisms and strategies
Luo, Y., Xu, H., Zhao, Y., Yang, B., & Zhang, Y. (2025) · Food & Function · doi:10.1039/d5fo03273c · Cited by 9
Tarasenko, T. N., Warren, E. B., Singh, B., Fuchs, A. L., Franco, J. L. M., Szibor, M., King, C., & McGuire, P. J. (2025) · Nature Communications · doi:10.1038/s41467-025-65910-w · Cited by 9
Zhu, L., Wu, K., You, J., Mi, W., Xu, J., Li, L., Yang, F., Xia, X., Yan, H., Li, F., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.12.001 · Cited by 9
Emerging roles and regulatory mechanisms involved in glutamine metabolism
Ryu, K. W., Fung, T. S., & Thompson, C. B. (2026) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2026.04.008 · Cited by 9
Engineering Tools for Regulating Hypoxia in Tumour Models
Kim, M. H., Green, S. D., Lin, C., & Koenig, H. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16759 · Cited by 9
MUC1 triggers lineage plasticity of Her2 positive mammary tumors
Pang, Z., Dong, X., Deng, H., Wang, C., Liao, X., Liao, C., Liao, Y., Tian, W., Cheng, J., Chen, G., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02320-y · Cited by 9
McDonald, J. G., Ivanova, P. T., & Brown, H. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-63438-2.00002-x · Cited by 11
The impact of transcription on metabolism in prostate and breast cancers
Poulose, N., Mills, I. G., & Steele, R. E. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0048 · Cited by 9
Tamoxifen modulates mitochondrial dynamics through AMPK and MAPK during nutrition deprivation
Gangipangi, V., Swetha, U. S., & Selvaraju, S. (2022) · Cell Biology International · doi:10.1002/cbin.11853 · Cited by 9
Mao, M., & Leonardi, D. (2019) · Europe PMC (PubMed Central) · Cited by 9
Targeting Metabolic Pathways in Kidney Cancer
Hoerner, C. R., Miao, S. Y., Hsieh, J. J.-D., & Fan, A. C. (2020) · The Cancer Journal · doi:10.1097/ppo.0000000000000472 · Cited by 9
Tamir, T. Y., Chaudhary, S., Li, A. X., Trojan, S., Flower, C. T., Vo, P., Cui, Y., Davis, J. C., Mukkamala, R. S., Venditti, F. N., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2025.05.007 · Cited by 8
Mitochondrial VHL rewires cell metabolism in hypoxia
Li, G., Pan, W., Wu, L., Cai, Z., Chen, H., Wu, X., Yu, T., Liao, K., Zhang, H., 温星桥, et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.11.013 · Cited by 10
Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights
Xiao, W., Tan, D., Zeng, W., Nie, X., & Wang, M. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102054 · Cited by 8
Pancreatic β cells put the glutamine engine in reverse
Lien, E. C., & Heiden, M. G. V. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.010 · Cited by 8
Prescription drugs and mitochondrial metabolism
Schmidt, C. A. (2022) · Bioscience Reports · doi:10.1042/bsr20211813 · Cited by 8
Costantini, S., & Budillon, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85062-9.00016-7 · Cited by 8
Xie, T., Chen, M., Nielsen, J., & Xia, J. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foac030 · Cited by 8
NADP+/NADPH in Metabolism and its Relation to Cardiovascular Pathologies
Sun, Y., Wu, D., & Hu, Q. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673275187231121054541 · Cited by 8
Wang, Y., Sun, K., Liu, Y., Lu, Y., Feng, D., & Qi, H. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106165 · Cited by 8
Chung, Y., & Wu, M. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.03.013 · Cited by 8
Deuterium Tracing to Interrogate Compartment-Specific NAD(P)H Metabolism in Cultured Mammalian Cells
Lim, E. W., Parker, S. J., & Metallo, C. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0159-4_4 · Cited by 8
Matsuda, F., Maeda, K., & Okahashi, N. (2020) · Scientific Reports · doi:10.1038/s41598-019-57146-8 · Cited by 8
What to feed or what not to feed-that is still the question
Lech, J. C., Dorfsman, S. I., Répás, Z., Krüger, T. P. J., Gyalai, I. M., & Boros, L. G. (2021) · Metabolomics · doi:10.1007/s11306-021-01855-7 · Cited by 8
Zhang, F., Lin, J., Zhu, D., Tang, Y., Lu, Y., Liu, Z., & Wang, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.970208 · Cited by 8
Metabolic reprogramming in the OPA1-deficient cells
Dai, W., Wang, Z., Wang, Q. A., Chan, D. C., & Jiang, L. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04542-5 · Cited by 9
Metabolic Fluxes in Cancer Metabolism
Günther, U. L., Chong, M., Volpari, T., Koczula, K. M., Atkins, K. L., Bunce, C. M., & Khanim, F. L. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1824-5_14 · Cited by 8
Racial disparity in metabolic regulation of cancer
Singh, P. K. (2017) · Frontiers in bioscience · doi:10.2741/4543 · Cited by 8
Metadata
- Authors
- Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Northwestern University (US)
- National Institutes of Health (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- Corresponding author
- Chandel, Navdeep S.
- DeBerardinis, Ralph J.
- ORCID
- Venue
- Nature
- Published
- 2011-11-20
- Volume
- 481
- Issue
- 7381
- Pages
- 385-388
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3262117
- OpenAlex
- W2092152920
- Cited by
- 1,328
- References
- 27
- Citations by year
- 2026: 81 · 2025: 92 · 2024: 63 · 2023: 70 · 2022: 107 · 2021: 107 · 2020: 91 · 2019: 88 · 2018: 82 · 2017: 84 · 2016: 96 · 2015: 98 · 2014: 99 · 2013: 86 · 2012: 80
- FWCI
- 29.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA123067, R01CA157996, T32CA009560)
- National Institute of General Medical Sciences (T32GM083831, T32GM008061)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK072565, K01DK078933, DK078933)
- National Center for Research Resources (P41RR002584, RR‐02584)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- reductive carboxylation, glutamine metabolism, IDH1, acetyl-CoA, lipogenesis, hypoxia, tumor growth, fumarate hydratase deficiency, renal carcinoma, TCA cycle
- MeSH terms
- Acetyl Coenzyme A, Animals, Carcinoma, Renal Cell, Electron Transport, Fumarate Hydratase, Glucose, Glutamine, Humans, Isocitrate Dehydrogenase, Kidney Neoplasms, Mitochondria, NADP, Neoplasms, Electron Transport Complex III, Cell Hypoxia, Citric Acid, Electron Transport Complex I, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
